Stocks to watch today : 19 March 2025

Market Gains on Positive Trends Indian benchmark indices posted significant gains in Tuesday's trading session, with the BSE Sensex soaring 1,131.31 points (1.53%) to end at 75,301.26 and the NSE's Nifty50 surging 325.55 points (1.45%) to settle at 22,834.30. The positive performance was driven by favorable global and domestic market conditions. Corporate Developments

has re-appointed Rajivnayan Rahulkumar Bajaj as the Managing Director & Chief Executive Officer for five consecutive years, effective April 1. The company's board has also approved an additional fund infusion of up to Rs 1,500 crore in its subsidiary, Bajaj Auto Credit. 's board is scheduled to meet on March 21 to consider fund raising through a debt issue. Life Insurance Corporation of India (LIC) is in advanced talks to acquire a substantial stake in a standalone health insurance company to expand its footprint in the health insurance market. Regulatory Updates !Dr Reddy's Laboratories, along with Nasdaq-listed Alvotech, announced that the USFDA has accepted a 351(k) Biologic License Application (BLA) submission for AVT03, a proposed biosimilar of Prolia (denosumab) and Xgeva (denosumab). has received final approval from the USFDA to manufacture Apalutamide tablets, an androgen receptor inhibitor used for the treatment of patients with metastatic castration-sensitive prostate cancer. Apalutamide tablets had annual sales of $1,099.8 million in the United States. Note : Follow risk management and position sizing at all times